Page 7 - Heart Transplant Guidelines
P. 7

Heart Function Service: Heart Transplant Guidelines

               Drug Protocols ............................................................................................................................................ 65

                  Protocol for Administration of Anti-thymocyte Globulin (Thymoglobulin) ............................................ 65
                    Premedication: .................................................................................................................................... 65

                    Dosing: ................................................................................................................................................ 65

                    IV Infusion: .......................................................................................................................................... 65
                    Anaphylaxis: ........................................................................................................................................ 65

                    Infectious Disease Prophylaxis: ........................................................................................................... 66
                    Contraindications: ............................................................................................................................... 66

                    Adverse Reactions: .............................................................................................................................. 66
                  Protocol for Administration of Basiliximab (Simulect®) ......................................................................... 67

                    Dose: ................................................................................................................................................... 67
                    Administration: ................................................................................................................................... 67

                    Side Effects: ......................................................................................................................................... 67
                  Protocol for Administration of Rituximab (Rituxan®) ............................................................................. 68

                    Premedication:  1 hr prior to infusion................................................................................................. 68

                    Dose: ................................................................................................................................................... 68
                    Infusion: .............................................................................................................................................. 68

                    Anaphylaxis: ........................................................................................................................................ 68
                    Drug Interactions: ............................................................................................................................... 68

                    Side Effects: ......................................................................................................................................... 69
                  Protocol for Administration of Intravenous Immunoglobulin (IVIG) ...................................................... 71

                  Protocols for the Administration of Bortezomib (Velcade®) .................................................................. 77

                  Protocol for Administration of Belatacept (Nulojix®) ............................................................................. 80
                  Protocol for Administration of Alemtuzumab (Campath®) .................................................................... 81

                  Protocols for the Administration of Eculizumab (Soliris®) ...................................................................... 82
                  Protocol for Administration of Valganciclovir (Valcyte®) ....................................................................... 84

               Normal Blood Pressure Values.................................................................................................................... 86
















               Updated December 14, 2018                                                                    7
   2   3   4   5   6   7   8   9   10   11   12